Natriumchloride Dirinco (Sodium Chloride)

Sodium Chloride, the active ingredient in Natriumchloride Dirinco, is an electrolyte presented as a solution for injection for intravenous use. It is employed to restore extracellular fluid volume and correct electrolyte imbalances in patients requiring fluid replacement, such as those with hypovolemia or dehydration. GNH USA supplies Natriumchloride Dirinco as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Natriumchloride Dirinco is an intravenous electrolyte solution used to manage conditions involving fluid loss and electrolyte disturbances. - Fluid replacement: rehydrates patients and restores circulating blood volume. - Electrolyte imbalance correction: normalizes sodium and chloride levels in the extracellular compartment. - Hypovolemia: treats low blood volume due to bleeding, burns, or severe dehydration.

Adverse reactions may occur with any intravenous therapy.

Common Side Effects: - Phlebitis at the infusion site: inflammation or pain. - Hypernatremia: elevated serum sodium if administered excessively. - Hyperchloremia: increased chloride levels leading to metabolic acidosis. - Fluid overload: signs of edema or pulmonary congestion.

Serious or Rare Side Effects: - Severe allergic reaction: anaphylaxis with rash, wheezing, or hypotension. - Electrolyte disturbances causing cardiac arrhythmias.

Use Natriumchloride Dirinco with clinical monitoring and appropriate indications. - Dosage adjustment: tailor infusion rate to patient’s fluid status and electrolyte levels. - Cardiac monitoring: observe for arrhythmias in patients with underlying heart disease. - Renal function: assess kidney function before and during therapy. - Compatibility: verify compatibility with other IV solutions before mixing. - Storage: Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Intravenous sodium chloride can affect the pharmacodynamics of several agents.

Major Interactions (Avoid): - Hypertonic solutions: concurrent infusion may cause severe hypernatremia. - Certain antibiotics (e.g., aminoglycosides): high sodium load can increase nephrotoxicity.

Moderate Interactions (Monitor Closely): - Diuretics: may require adjustment of sodium chloride infusion rate. - ACE inhibitors or ARBs: monitor blood pressure and electrolyte balance. - Corticosteroids: may potentiate fluid retention, requiring careful volume assessment.